Related Experiment Video
Updated: Jun 4, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development
Jing Wang1, Zenghui Li2, Yifan He3
1Department of Gynecology, Yantai Yuhuangding Hospital, Shandong University, Yantai, Shandong 264000, China.
Abstract:
Cervical cancer (CCA) is the predominant cause of fatalities from gynecologic malignancies, with metastasis responsible for 80 % of cancer-related mortalities. This study preliminarily examined the involvement of Sialic Acid Binding Ig Like Lectin 15 (Siglec-15) in the development of CCA and its probable mechanisms. We assessed the capacity of Siglec-15 to modulate CCA progression by establishing knockdown and overexpression Siglec-15 cell lines, supplemented with animal models, using both in vivo and in vitro dual investigations. Our findings indicate that Siglec-15 is significantly expressed in CCA cell lines and is intimately associated with the proliferation, migration, and invasion capabilities of CCA cells, as well as mitochondrial ROS homeostasis. The suppression of Siglec-15 expression markedly reduced tumor growth in mice, potentially due to Siglec-15's role in regulating the Mitogen-Activated Protein Kinase (MAPK) signaling pathway, which mediates the retrograde regulation of mitochondrial ROS homeostasis. Siglec-15 may emerge as a novel therapeutic target and prognostic marker for patients with CCA.
Insights
Sialic Acid Binding Ig Like Lectin 15 (Siglec-15) drives cervical cancer (CCA) progression by affecting cell capabilities and mitochondrial function. Suppressing Siglec-15 reduced tumor growth, suggesting it as a potential therapeutic target for CCA.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cervical cancer (CCA) is a leading cause of cancer death in women, with metastasis being a major factor in mortality.
- Understanding the molecular mechanisms driving CCA progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of Sialic Acid Binding Ig Like Lectin 15 (Siglec-15) in cervical cancer development.
- To elucidate the potential mechanisms by which Siglec-15 influences CCA progression.
Main Methods:
- Established Siglec-15 knockdown and overexpression cell lines for cervical cancer.
- Utilized in vivo and in vitro animal models for dual investigations.
- Assessed Siglec-15's impact on cell proliferation, migration, invasion, and mitochondrial reactive oxygen species (ROS) homeostasis.
Main Results:
- Siglec-15 is significantly expressed in cervical cancer cell lines.
- Siglec-15 expression correlates with enhanced proliferation, migration, and invasion capabilities of CCA cells.
- Suppression of Siglec-15 reduced tumor growth in mice, linked to the Mitogen-Activated Protein Kinase (MAPK) pathway and mitochondrial ROS regulation.
Conclusions:
- Siglec-15 plays a significant role in cervical cancer progression.
- Siglec-15 influences key cellular processes and mitochondrial homeostasis in CCA.
- Siglec-15 presents a potential novel therapeutic target and prognostic marker for cervical cancer patients.
More Related Videos
Related Concept Videos
Non-LTR Retrotransposons
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mechanisms of Retrovirus-induced Cancers
Replicative Cell Senescence

